Lithium Citrate Anhydrous
A anhydrous salt form of lithium with the same therapeutic properties. A mood-stabilizing element used as lithium salts to treat and prevent episodes of mania, depression, and bipolar disorder, and studied for potential neuroprotective effects in Alzheimer's disease.
分子量
210.0000 g/mol
TPSA
141.00 Ų
治療領域
作用機序
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
2D構造
Cite this structure
Embed this structure
SMILES
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]
InChI
InChI=1S/C6H8O7.3Li/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3
Molecular Formula
C6H5Li3O7
HBD / HBA
1 / 7
回転可能結合数
2
重原子数
16
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
よくある質問
A anhydrous salt form of lithium with the same therapeutic properties. A mood-stabilizing element used as lithium salts to treat and prevent episodes of mania, depression, and bipolar disorder, and studied for potential neuroprotective effects in Alzheimer's disease.
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Yes, Lithium Citrate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201170. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 13520. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="lithium-citrate-anhydrous"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/lithium-citrate-anhydrous/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/lithium-citrate-anhydrous/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/lithium-citrate-anhydrous/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="lithium-citrate-anhydrous"></drugfyi-drug>